Literature DB >> 17080769

Bayesian decision procedures for binary and continuous bivariate dose-escalation studies.

Yinghui Zhou1, John Whitehead, Elisa Bonvini, John W Stevens.   

Abstract

In this paper, Bayesian decision procedures are developed for dose-escalation studies based on binary measures of undesirable events and continuous measures of therapeutic benefit. The methods generalize earlier approaches where undesirable events and therapeutic benefit are both binary. A logistic regression model is used to model the binary responses, while a linear regression model is used to model the continuous responses. Prior distributions for the unknown model parameters are suggested. A gain function is discussed and an optional safety constraint is included.

Mesh:

Year:  2006        PMID: 17080769     DOI: 10.1002/pst.222

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  3 in total

1.  Optimizing natural killer cell doses for heterogeneous cancer patients on the basis of multiple event times.

Authors:  Juhee Lee; Peter F Thall; Katy Rezvani
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2018-03-15       Impact factor: 1.864

2.  Parametric Dose Standardization for Optimizing Two-Agent Combinations in a Phase I-II Trial with Ordinal Outcomes.

Authors:  Peter F Thall; Hoang Q Nguyen; Ralph G Zinner
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2016-06-11       Impact factor: 1.864

3.  Bayesian auxiliary variable model for birth records data with qualitative and quantitative responses.

Authors:  Xiaoning Kang; Shyam Ranganathan; Lulu Kang; Julia Gohlke; Xinwei Deng
Journal:  J Stat Comput Simul       Date:  2021-05-16       Impact factor: 1.424

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.